Skip to content

Randomised trial, 2024

Does emotion-focused therapy help PMDD symptoms?

Yes. Emotion-focused therapy significantly reduced PMDD symptoms, emotion regulation difficulties, and depression and stress over 16 weeks compared to a waiting list control.

Moderate study design 48 women aged 18-44 with PMDD (44 completed)

What they did

A randomized controlled trial in 48 women aged 18-44 with PMDD. The treatment group received 16 weeks of emotion-focused therapy while the control group was placed on a waiting list. Symptoms were measured before treatment, right after treatment, and again three months later.

What they found

The emotion-focused therapy group showed significant decreases in total PMDD symptoms, emotion regulation difficulties, and depression, anxiety, and stress scores (all p<0.05) compared to the waiting list control.

What it means for you

Emotion-focused therapy may be an effective psychological treatment for PMDD. The main limits are the relatively small sample size (48 women, 44 completed) and use of a waiting list rather than an active placebo control.

48

women enrolled

44

completed study

16

weeks of therapy

About the study

Original title
Emotion-focused therapy for women with premenstrual dysphoric disorder: a randomized clinical controlled trial
Authors
Dehnavi SI, Mortazavi SS, Ramezani MA et al.
Journal
BMC psychiatry
Year
2024
Study design
Randomised trial
Participants
48
What was tested
16 weeks of emotion-focused therapy vs waiting list control
Open access
Yes
Original abstract

Background: Premenstrual dysphoric disorder (PMDD) is a debilitating condition, affecting women of reproductive age. It is characterized by severe periodic physical and psychological symptoms, which end after the onset of menstruation. This study aimed to evaluate the effectiveness of emotion-focused therapy (EFT) for PMDD patients. Methods: A total of 48 PMDD women, in the age range of 18-44 years, were randomly assigned to two intervention and control groups. The intervention group participated in 16 weeks of EFT treatment, while the control group was selected based on the waiting list (waitlist control group) and followed-up after three months. Forty-four patients finally completed this study. The participants completed the Premenstrual Syndrome Screening Tool (PSST), Difficulties in Emotion Regulation Scale (DERS), and Depression Anxiety Stress Scale-21 (DASS-21) in the first premenstrual period before treatment, the first premenstrual period after treatment, and the premenstrual period three months after treatment. Results: Based on the repeated measure analysis of variances, the total score of DERS and the total score of PSST decreased significantly (P 0.05). Conclusion: Based on the present results, EFT can be an effective treatment for alleviating the symptoms of PMDD. This treatment can reduce the emotion regulation difficulties of women with PMDD and alleviate the symptoms of depression and stress. Trial registration: Iranian Registry of Clinical Trials, IRCT ID: IRCT20220920055998N1, Registered on: 12/2/2023.

Reproduced under CC-BY.

Topics